Nanozymes: The Next Generation of Artificial Enzymes

Since their discovery in the early 2000s, nanozymes have gained attention for their durability under extreme conditions and versatility in applications ranging from medicine to industry. Made from materials like metal oxides, noble metals, and carbon nanostructures, nanozymes are redefining the future of catalysis and biochemistry.

- Vijeta Sah

The nanozyme market is set to soar, with its value estimated at $5.13 billion in 2024. Forecasts predict a remarkable climb from $6.54 billion in 2025 to an impressive $57.95 billion by 2034, driven by a robust CAGR of around 27.4 per cent during this period. This explosive growth underscores the transformative potential of nanozymes across diverse industries.

The healthcare sector is anticipated to dominate, driven by applications in diagnostics, drug delivery, and personalised medicine. Environmental and agricultural sectors are also witnessing increased adoption, with nanozymes being utilised for pollutant degradation and crop protection.

Regionally, North America currently leads the market, accounting for over 42 per cent of the revenue share in 2023, due to robust research and development activities and a well-established healthcare infrastructure. Asia-Pacific is projected to exhibit the fastest growth, fueled by increasing healthcare expenditure and the prevalence of chronic diseases in countries like China and India.